Rafael A Medina Selected Research

Vaccines

1/2023	Cross-protection of commercial vaccines against Chilean swine influenza A virus using the guinea pig model as a surrogate.
4/2022	Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals.
1/2022	Clinical and epidemiological characteristics of SARS-CoV-2 virus in ambulatory children under 2 years old.
1/2022	Assessment of Mutations Associated With Genomic Variants of SARS-CoV-2: RT-qPCR as a Rapid and Affordable Tool to Monitoring Known Circulating Variants in Chile, 2021.
5/2021	Long-lasting neutralizing antibody responses in SARS-CoV-2 seropositive individuals are robustly boosted by immunization with the CoronaVac and BNT162b2 vaccines.
2/2015	Development of a reverse genetic system for infectious salmon anemia virus: rescue of recombinant fluorescent virus by using salmon internal transcribed spacer region 1 as a novel promoter.
6/2010	Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus.
1/2010	Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rafael A Medina Research Topics

Disease

13	Infections 01/2022 - 02/2007
4	COVID-19 11/2022 - 01/2022
4	Human Influenza (Influenza) 11/2022 - 01/2010
2	Convalescence 04/2022 - 09/2020
1	Bacterial Pneumonia 01/2023
1	Obesity 01/2023
1	Orthomyxoviridae Infections 01/2023
1	Superinfection 01/2023
1	Pneumonia (Pneumonitis) 11/2022
1	Bites and Stings (Sting) 01/2021
1	Zika Virus Infection 01/2021
1	Hantavirus Infections 03/2009

Drug/Important Bio-Agent (IBA)

9	AntibodiesIBA 01/2022 - 01/2010
8	VaccinesIBA 01/2023 - 01/2010
3	Neutralizing AntibodiesIBA 11/2022 - 05/2021
3	RNA (Ribonucleic Acid)IBA 01/2021 - 03/2009
2	sinovac COVID-19 vaccineIBA 04/2022 - 05/2021
2	BNT162 VaccineIBA 04/2022 - 05/2021
2	Hemagglutinins (Hemagglutinin)IBA 01/2017 - 05/2013
1	Oxygen (Dioxygen)IBA 01/2023
1	AutoantibodiesIBA 11/2022
1	Interferon Type IIBA 11/2022
1	Yellow Fever Vaccine (Vaccine, Yellow Fever)FDA Link 11/2022
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 12/2021
1	Aligeron (AS 2)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Neuraminidase (Sialidase)IBA 01/2017
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 05/2013
1	Oseltamivir (Tamiflu)FDA Link 11/2010
1	Ribavirin (Virazole)FDA LinkGeneric 02/2007
1	IntegrinsIBA 02/2007